Davies B, Miles D W, Happerfield L C, Naylor M S, Bobrow L G, Rubens R D, Balkwill F R
Imperial Cancer Research Fund, Biological Therapy Laboratory, London, UK.
Br J Cancer. 1993 May;67(5):1126-31. doi: 10.1038/bjc.1993.207.
Using zymography and computer assisted image analysis, we have measured the levels of type IV collagenases in biopsies from normal breast, and benign and malignant breast disease. The 92 kDa form was present in three of 11 cases of normal/benign disease, three of nine grade I tumours, four of 12 grade II tumours, but 11 of 11 grade III tumours. Mean levels were higher in grade III tumours (P < 0.0001). When the levels of 72 kDa collagenase and its active 62 kDa form were considered together, there was no difference between the benign and malignant cases (P = 0.55), but the amount of active enzyme, considered as a proportion of the 62 + 72 kDa forms, was significantly higher in malignant disease (P = 0.003). There was also a trend towards a higher proportion of active enzyme with increasing tumour grade (P < 0.0001). In situ hybridisation and immunohistochemistry studies showed that that mRNA and protein for the 92 kDa enzyme was primarily found in the tumour stroma. mRNA for the 72 kDa enzyme was also found in stromal areas. This study demonstrates a clear relationship between production of Type IV collagenases and malignant breast disease. Inhibitors of these enzymes may be of value in preventing metastatic disease.
通过酶谱分析和计算机辅助图像分析,我们测量了正常乳腺、良性和恶性乳腺疾病活检组织中IV型胶原酶的水平。在11例正常/良性疾病病例中有3例存在92 kDa形式,9例I级肿瘤中有3例,12例II级肿瘤中有4例,但11例III级肿瘤中有11例。III级肿瘤中的平均水平更高(P < 0.0001)。当将72 kDa胶原酶及其活性62 kDa形式的水平一起考虑时,良性和恶性病例之间没有差异(P = 0.55),但活性酶的量(以62 + 72 kDa形式的比例计算)在恶性疾病中显著更高(P = 0.003)。随着肿瘤分级增加,活性酶的比例也有升高趋势(P < 0.0001)。原位杂交和免疫组织化学研究表明,92 kDa酶的mRNA和蛋白主要在肿瘤基质中发现。72 kDa酶的mRNA也在基质区域中发现。这项研究证明了IV型胶原酶的产生与恶性乳腺疾病之间存在明确关系。这些酶的抑制剂可能在预防转移性疾病方面具有价值。